CEA levels in patients with colorectal polyps.

Area of Science:

• Gastroenterology
• Oncology
• Clinical Chemistry

Background:

• Colorectal polyps are common, and some have malignant potential.
• Carcinoembryonic antigen (CEA) is a tumor marker, but its role in colorectal adenomas is not fully understood.
• Understanding factors associated with elevated CEA in polyp patients is crucial for risk stratification.

Purpose of the Study:

• To investigate the prevalence of elevated preoperative plasma CEA levels in patients with colorectal adenomas.
• To determine if CEA levels correlate with specific histological patterns of adenomas.
• To assess the association between CEA levels and patient/tumor characteristics.

Main Methods:

• Prospective measurement of preoperative plasma CEA levels in 93 patients undergoing colonoscopic removal of colorectal adenomas.
• Exclusion of patients with inflammatory bowel disease, prior cancer history, or liver disease.
• Statistical analysis to identify associations between elevated CEA and factors like age, adenoma type (villous, tubular), tumor size, and dysplasia.

Main Results:

• Fifteen percent of patients had elevated CEA levels (≥ 2.5 ng/ml).
• Elevated CEA showed increased association with older age, villous adenomas (2-4 fold increase), and larger tumor size (> 2.3 cm diameter; 2 fold increase).
• No significant association was found with foci of dysplasia or carcinoma in situ as a sole factor.

Conclusions:

• Elevated CEA levels in patients with colorectal adenomas may be linked to specific histological features and tumor size.
• A subset of patients with elevated CEA had concurrent findings suggestive of higher risk, including villous components, carcinoma in situ, or concurrent carcinoma.
• This preliminary study suggests that elevated CEA in adenoma patients might predict a higher risk for colorectal carcinoma, warranting further investigation.